DalsnaFinance › IPOs › Maplight Therapeutics Inc › IPO
MapLight Therapeutics, Inc. completed its initial public offering on NASDAQ on October 27, 2025, pricing at $17.00 a share.
| Ticker | MPLT |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | October 27, 2025 |
| Offering price | $17.00 |
| Shares offered | 14,750,000 |
| Total raised | $251M |
MapLight Therapeutics, Inc. sold 14,750,000 shares at $17.00 each on NASDAQ. Multiplied out, that is $250.8 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $251 million total recorded for the deal.
Measured by money raised, MapLight Therapeutics, Inc. was the 120th largest of 473 completed IPOs with a recorded deal size that this site tracks since October 5, 2024. The median deal in the same window raised $200 million.
Among the 342 listings on NASDAQ alone, it is the 72nd largest.
October 2025 saw 26 completed IPOs in the site's data; by amount raised, MapLight Therapeutics, Inc. was the 7th largest of the 26 deals with a recorded size.
Its $17.00 offer price was tied for the 96th highest (level with 12 other listings) of the 479 listings in the window with a recorded price. A share price on its own says nothing about a company's value; it depends on how many shares exist.
MapLight Therapeutics, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for MapLight Therapeutics, Inc.. This page is general information, not investment advice.